Ruxolitinib Phosphate
Ruxolitinib Phosphate, sold under the brand names Jakafi and Jakavi, is a medication for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow.Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. Reference standards of Ruxolitinib Phosphate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Ruxolitinib Phosphate - API Standards
[catalogue_number] => PA 18 1110000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[weight] => 404.37
[form] => C17H21N6O4P
[cas] => 1092939-17-7
[pslug] => 1092939-17-7-ruxolitinib-phosphate-api-pa181110000
[latest_product] => 0
[linkproducts] => 1
[offers_id] => 1
[offers_name] => Spring Season Offer
[offers_status] => 1
[offers_start_date] => 2024-03-27
[offers_end_date] => 2024-03-31
[pageview] => 2
[offers_slug] => spring-season-offer
[offers_product_id] => 3969
[offers_product_code] => PA 18 1110000
[offers_master_id] => 1
[offer_percentage] => 20% OFF
[offers_product_main_cat] => Pharmaceutical Reference Standards
)
Ruxolitinib Phosphate - API Standards
Catalogue No.:PA 18 1110000
Molecular Formula : C17H21N6O4P
Molecular Weight : 404.37